MaPyIRS Variant Enhances AzK Incorporation Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current orthogonal non-canonical amino acid (ncAA) translation systems, particularly those using the wildtype MaPyIRS/MatRNACUAPyl pair, are less efficient in incorporating azido-containing lysine derivatives like AzK, limiting their application in site-specific protein modification and bioorthogonal coupling reactions.

Innovation Solution

A variant of pyrrolysyl-tRNA synthetase, MaPyIRS, with specific substitutions at positions 129 and 168 (M129L+V168C), enhances the efficiency of AzK incorporation, matching the performance of the benchmark MmPyIRS/MmtRNACUAPyl pair, and maintains orthogonality with canonical amino acids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the wildtype MaPyIRS/MatRNACUAPyl orthogonal translation system is used, then the system maintains orthogonality with canonical amino acids, but the efficiency of incorporating azido-containing lysine derivatives like AzK is reduced

Engineering Contradiction:
ImproveorthogonalityVSAvoidincorporation efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies parameter changes by modifying specific amino acid residues in the MaPyIRS enzyme (positions 129 and 168) to alter its substrate binding properties. The M129L and V168C substitutions change the enzyme's parameters to enhance AzK incorporation efficiency while preserving orthogonality with canonical amino acids, directly resolving the contradiction between reliability and productivity

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If the wildtype MaPyIRS/MatRNACUAPyl pair is used, then the system structure is simple and well-established, but the performance in AzK incorporation is inferior to the benchmark MmPyIRS/MmtRNACUAPyl pair

Engineering Contradiction:
Improvesystem structureVSAvoidAzK incorporation efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent applies local quality by making targeted local modifications to the MaPyIRS enzyme structure at specific positions (129 and 168) rather than redesigning the entire system. This localized approach improves AzK incorporation efficiency while maintaining the overall simplicity and orthogonality of the translation system structure

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The MaPyIRS M129L V168C variant significantly improves AzK incorporation into proteins, achieving comparable or superior efficiency to the benchmark system, allowing for more cost-effective and efficient site-specific labeling and bioorthogonal modifications.

Implementation Method 1

a variant of pyrrolysyl-tRNA synthetase... wherein said variant has pyrrolysyl-tRNA synthetase activity... capable of catalyzing the aminoacylation of its cognate tRNA with a non-canonical amino acid

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS20230287383A1PYRROLYSYL-tRNA SYNTHETASE VARIANTS AND USES THEREOF
Publication Date: 2023.09.14 ENGENES BIOTECH GMBH
  • US20230287383A1 patent drawing
  • US20230287383A1 patent drawing
  • US20230287383A1 patent drawing

AI summary

The present invention relates to the field of pyrrolysyl-tRNA synthetases, their variants and uses thereof. Particularly, the present invention relates to variants (mutants) of parent pyrrolysyl-tRNA synthetases, wherein said variants have pyrrolysyl-tRNA synthetase activity and exhibit altered properties relative to the corresponding parent pyrrolysyl-tRNA synthetase.